Drug stability testing evaluates how the quality of oral pharmaceutical products changes under environmental conditions over time. It helps manufacturers understand the effects of temperature, humidity, light, and packaging on medicines such as tablets, capsules, and oral liquids. These studies support the establishment of appropriate storage conditions, shelf life, and expiry dates. Stability testing also examines product characteristics, including potency, degradation products, dissolution, and physical appearance. Following established scientific and regulatory guidelines helps ensure that oral medicines maintain their required quality, safety, and performance throughout their intended storage period.
Oral pharmaceutical products must maintain their quality throughout manufacturing, distribution, storage, and use. Drug stability testing provides scientific evidence about how active pharmaceutical ingredients and finished formulations respond to environmental conditions over time. Changes in temperature, moisture, oxygen exposure, or light can affect a medicine's chemical composition and physical characteristics. Stability studies help identify these changes and establish suitable storage recommendations and expiry periods.
Tablets, capsules, powders, suspensions, and oral solutions may demonstrate different stability characteristics because of their formulation ingredients and physical properties. Therefore, testing methods are selected according to the product's composition, dosage form, packaging, and intended storage conditions.
Stability testing involves storing pharmaceutical samples under defined conditions and examining their quality at predetermined intervals. The results help establish whether a product continues to meet its specifications throughout its proposed shelf life.
Several types of stability studies may be used during pharmaceutical development and after manufacturing processes are established.
Long term stability testing: Samples are stored under recommended conditions for an extended period to evaluate changes relevant to the proposed shelf life.
Accelerated stability testing: Products are exposed to elevated temperature and humidity, where appropriate, to help assess potential degradation and support early development decisions.
Intermediate stability testing: Additional storage conditions may be used when accelerated studies show significant changes and applicable guidelines recommend further evaluation.
Photostability testing: Studies assess how exposure to light affects the medicine, its ingredients, and sometimes its packaging.
In use stability testing: Where relevant, testing evaluates quality after a container is opened or a product is prepared for use, such as a reconstituted oral suspension.
Stress testing: Products or active ingredients may be exposed to more severe conditions to identify degradation pathways and understand the stability-indicating capability of analytical methods.
The selection of storage conditions depends on the product, intended market, packaging, and applicable regulatory requirements. International guidance, including relevant International Council for Harmonisation guidelines, provides frameworks for designing and conducting pharmaceutical stability studies.
Stability testing evaluates several quality characteristics to determine whether an oral pharmaceutical product remains within its established specifications. The specific tests depend on the dosage form, formulation, and potential degradation mechanisms.
Important parameters and influencing factors include:
Assay and potency: Analytical testing measures the amount of active pharmaceutical ingredient present and identifies changes that could affect product strength.
Degradation products: Testing identifies and monitors relevant impurities that may develop as the medicine ages or experiences environmental exposure.
Dissolution and disintegration: For tablets and capsules, these tests help assess whether the product continues to release its active ingredient appropriately under specified laboratory conditions.
Physical appearance: Changes in colour, odour, texture, hardness, or visible condition can indicate potential instability.
Moisture content: Water uptake or loss can affect tablet integrity, capsule properties, chemical reactions, and powder flow.
Microbiological quality: Oral liquids and other susceptible formulations may require appropriate microbial testing, including assessments of preservative effectiveness where applicable.
Packaging compatibility: Containers, closures, and protective materials can influence moisture transmission, oxygen exposure, light protection, and interactions with the formulation.
Temperature and humidity are important factors, but their effects vary across products. Some formulations are particularly sensitive to moisture, while others may undergo oxidation, hydrolysis, or light-induced degradation. Packaging selection and storage recommendations should therefore reflect the stability data generated for the specific product.
Stability results must be evaluated using validated or appropriately qualified analytical procedures, established acceptance criteria, and suitable documentation practices. Manufacturers use these findings to support shelf life assignments, expiry dating, storage instructions, and ongoing quality monitoring in accordance with applicable regulatory expectations.